Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study.

Chang CH, Shau WY, Kuo CW, Chen ST, Lai MS.

Stroke. 2010 Sep;41(9):1884-90. doi: 10.1161/STROKEAHA.110.585828. Epub 2010 Jul 29.

2.

Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs.

Lee CH, Wang JD, Chen PC.

Pharmacoepidemiol Drug Saf. 2010 Jul;19(7):708-14. doi: 10.1002/pds.1966.

PMID:
20582911
3.

Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community.

Mangoni AA, Woodman RJ, Gaganis P, Gilbert AL, Knights KM.

Br J Clin Pharmacol. 2010 Jun;69(6):689-700. doi: 10.1111/j.1365-2125.2010.03627.x.

4.

Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.

Roumie CL, Choma NN, Kaltenbach L, Mitchel EF Jr, Arbogast PG, Griffin MR.

Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1053-63. doi: 10.1002/pds.1820.

PMID:
19637402
5.

An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.

Farkouh ME, Greenberg BP.

Am J Cardiol. 2009 May 1;103(9):1227-37. doi: 10.1016/j.amjcard.2009.01.014. Review.

PMID:
19406264
6.

Defining the problem of treating the patient with hypertension and arthritis pain.

White WB.

Am J Med. 2009 May;122(5 Suppl):S3-9. doi: 10.1016/j.amjmed.2009.03.002. Review.

PMID:
19393824
7.

Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.

Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosbøl EL, Sørensen R, Folke F, Buch P, Gadsbøll N, Rasmussen S, Poulsen HE, Køber L, Madsen M, Torp-Pedersen C.

Arch Intern Med. 2009 Jan 26;169(2):141-9. doi: 10.1001/archinternmed.2008.525.

PMID:
19171810
8.

Cardiovascular risk associated with nonsteroidal anti-inflammatory drugs.

Hermann M.

Curr Rheumatol Rep. 2009 Feb;11(1):31-5. Review.

PMID:
19171109
9.

Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.

García Rodríguez LA, Tacconelli S, Patrignani P.

J Am Coll Cardiol. 2008 Nov 11;52(20):1628-36. doi: 10.1016/j.jacc.2008.08.041.

10.

The editor's roundtable: nonsteroidal antiinflammatory drugs and cardiovascular risk.

Friedewald VE Jr, Bennett JS, Packer M, Roberts WC, Williams GW.

Am J Cardiol. 2008 Oct 15;102(8):1046-55. doi: 10.1016/j.amjcard.2008.08.004. Review. No abstract available.

PMID:
18929707
11.

Cyclooxygenase-2 inhibitors, nonsteroidal anti-inflammatory drugs, and cardiovascular risk.

Vardeny O, Solomon SD.

Cardiol Clin. 2008 Nov;26(4):589-601. doi: 10.1016/j.ccl.2008.06.004.

PMID:
18929233
12.

The case-crossover study design in pharmacoepidemiology.

Delaney JA, Suissa S.

Stat Methods Med Res. 2009 Feb;18(1):53-65. doi: 10.1177/0962280208092346. Epub 2008 Sep 2.

PMID:
18765504
13.

Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction?

van Staa TP, Rietbrock S, Setakis E, Leufkens HG.

J Intern Med. 2008 Nov;264(5):481-92. doi: 10.1111/j.1365-2796.2008.01991.x. Epub 2008 Jun 25.

14.

The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.

van der Linden MW, van der Bij S, Welsing P, Kuipers EJ, Herings RM.

Ann Rheum Dis. 2009 May;68(5):668-73. doi: 10.1136/ard.2007.087254. Epub 2008 May 21.

PMID:
18495734
16.

The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people.

Fosbøl EL, Gislason GH, Jacobsen S, Abildstrom SZ, Hansen ML, Schramm TK, Folke F, Sørensen R, Rasmussen JN, Køber L, Madsen M, Torp-Pedersen C.

Pharmacoepidemiol Drug Saf. 2008 Aug;17(8):822-33. doi: 10.1002/pds.1592.

PMID:
18383428
17.

Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis.

Solomon SD, Wittes J, Finn PV, Fowler R, Viner J, Bertagnolli MM, Arber N, Levin B, Meinert CL, Martin B, Pater JL, Goss PE, Lance P, Obara S, Chew EY, Kim J, Arndt G, Hawk E; Cross Trial Safety Assessment Group.

Circulation. 2008 Apr 22;117(16):2104-13. doi: 10.1161/CIRCULATIONAHA.108.764530. Epub 2008 Mar 31.

18.

Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs.

Hammad TA, Graham DJ, Staffa JA, Kornegay CJ, Dal Pan GJ.

Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):315-21. doi: 10.1002/pds.1560.

PMID:
18302311
19.

Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.

Hennekens CH, Borzak S.

J Cardiovasc Pharmacol Ther. 2008 Mar;13(1):41-50. doi: 10.1177/1074248407312990.

PMID:
18287589

Supplemental Content

Support Center